The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families

Cancer Letters

Volumn 245, Issue 1-2, 2007, Pages 96-102

  Achatz, Maria Isabel Waddington ^a,b   Olivier, Magali ^c   Calvez, Florence Le ^c   Martel Planche, Ghyslaine ^c   Lopes, Ademar ^b   Rossi, Benedito Mauro ^b   Ashton Prolla, Patricia ^d,e   Giugliani, Roberto ^d,e   Palmero, Edenir Inez ^e   Vargas, Fernando Regla ^f   Rocha, José Claudio Casali Da ^b   Vettore, Andre Luiz ^a   Hainaut, Pierre ^c  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

151623 (LFS); Adrenocortical carcinomas; Database: http: www p53.iarc.fr; GenBank: X54156; Germline mutations; IARC TP53; Li Fraumeni; OMIM: 191170 (TP53); p53; R337H; TP53

Indexed keywords

ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADULT; ALLELE; ARTICLE; BRAIN CANCER; BRAZIL; BREAST CANCER; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; FAMILIAL CANCER; FAMILY HISTORY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SCREENING; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BRAZIL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LI-FRAUMENI SYNDROME; MALE; MUTATION, MISSENSE; NEOPLASTIC SYNDROMES, HEREDITARY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33845645820     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.12.039     Document Type: Article

References (20)

1. Li F.P., and Fraumeni Jr. J.F. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome. J. Natl Cancer Inst. 43 (1969) 1365-1373
2. Birch J.M., Alston R.D., McNally R.J., Evans D.G., Kelsey A.M., Harris M., et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20 (2001) 4621-4628
3. Nichols K.E., Malkin D., Garber J.E., Fraumeni Jr. J.F., and Li F.P. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 83-87
4. Birch J.M., Hartley A.L., Tricker K.J., Prosser J., Condie A., Kelsey A.M., et al. Prevalence and diversity of constitutional mutations in the p53 gene among 21 li-fraumeni families. Cancer Res. 54 (1994) 1298-1304
5. Eeles R.A. Germline mutations in the TP53 gene. Cancer Surv. 25 (1995) 101-124
6. Malkin D., Li F.P., Strong L.C., Fraumeni Jr. J.F., Nelson C.E., Kim D.H., et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250 (1990) 1233-1238
7. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
8. Olivier M., Goldgar D.E., Sodha N., Ohgaki H., Kleihues P., Hainaut P., and Eeles R.A. Li-fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res. 63 (2003) 6643-6650
9. Ribeiro R.C., Sandrini F., Figueiredo B., Zambetti G.P., Michalkiewicz E., Lafferty A.R., et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl Acad. Sci. USA 98 (2001) 9330-9335
10. Latronico A.C., Pinto E.M., Domenice S., Fragoso M.C., Martin R.M., Zerbini M.C., et al. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 86 (2001) 4970-4973
11. DiGiammarino E.L., Lee A.S., Cadwell C., Zhang W., Bothner B., Ribeiro R.C., et al. A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat. Struct. Biol. 9 (2002) 12-16
12. Birch J.M. Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges. Br. J. Cancer 66 (1992) 424-426
13. Eeles R.A., Bartkova J., Lane D.P., and Bartek J. The role of TP53 in breast cancer development. Cancer Surv. 18 (1993) 57-75
14. R.A. Eeles, Germline mutations in the TP53 gene in Breast and Other Cancers, Thesis, University of London, 2000.
15. English D., and Andersen B.R. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J. Immunol. Methods 5 (1974) 249-252
16. Le Calvez F., Ahman A., Tonisson N., Lambert J., Temam S., Brennan P., et al. Arrayed primer extension resequencing of mutations in the TP53 tumor suppressor gene: comparison with denaturing HPLC and direct sequencing. Clin. Chem. 51 (2005) 1284-1287
17. Kato S., Han S.Y., Liu W., Otsuka K., Shibata H., Kanamaru R., and Ishioka C. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Natl Acad. Sci. USA 100 (2003) 8424-8429
18. Pinto E.M., Billerbeck A.E., Villares M.C., Domenice S., Mendonca B.B., and Latronico A.C. Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arq. Bras. Endocrinol. Metabol. 48 (2004) 647-650
19. Figueiredo B.C., Sandrini R., Zambetti G.P., Pereira R.M., Cheng C., Liu W., et al. Penetrance of adrenocortical tumors associated with the germline TP53 R337H mutation. J. Med. Genet. (2005)
20. Varley J.M., McGown G., Horncroft M., Ames L.A., Margison G.P., and Forster G. Are there low-penetrance TP53 Alleles? Evidence from childhood adrenocortical tumors. Am. J. Hum. Genet. 65 (1999) 995-1006